Hepatic Encephalopathy

Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems

TReatment for ImmUne Mediated PathopHysiology

Evaluation of the Outcome of Fecal Microbiota Transplantation

Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis

The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

VICIS - Vienna Cirrhosis Study

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis

Affect of Melatonin on Sleep and Cognition in Cirrhosis

Mechanisms of Perioperative Systemic Inflammation in the Development of PND in Cirrhotic Patients

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE